Decision and Details
The Company decided to establish the Internal Investigation Committee with the approval of the Representative Director in accordance with the Company’s regulations. The Company and SDS will implement the measures to prevent recurrence.Receipt of the Internal Investigation Committee’s investigation report and measures to prevent recurrence
Although ongoing training is a statutory obligation, it was not sufficiently prioritized company-wide, and completion by the deadline was prioritized without adequate arrangements for training time, locations, staffing or management systems.
As of the present time, the impact on the Company’s consolidated results is immaterial.
| Item | Details |
|---|---|
| Matter Covered | Receipt of the Internal Investigation Committee’s investigation report and measures to prevent recurrence |
| Decision-Making Body | The Company decided to establish the Internal Investigation Committee with the approval of the Representative Director in accordance with the Company’s regulations. The Company and SDS will implement the measures to prevent recurrence. |
| Decision Date | 22 May 2026 (decision to establish the Internal Investigation Committee); 16 June 2026 (receipt of the report) |
| Implementation Date | 16 June 2026 (receipt and publication of the report; completed). FY2026 ongoing training has already begun. |
| Period Covered | FY2025 ongoing training and ongoing training from FY2026 onward |
| Amount | Voluntary return of a portion of directors’ compensation (the individuals covered, return percentages and period will be disclosed after the Board of Directors makes its decision) |
| Quantity / scale | 1,855 people were surveyed, of whom 1,747 provided valid responses (94.2%). Of these, 54 people (3.1%) acknowledged having someone else attend on their behalf, 514 people (29.4%) had experienced training attendance under circumstances not normally anticipated, and 648 people (37.1%) had engaged in unpaid overtime or similar work in connection with the training. Proxy attendance was identified for a total of 21 people, comprising 18 at the Kita 8-jo store and 3 at the Niseko Hirafu store. |
| Impact on Business Performance | As of the present time, the impact on the Company’s consolidated results is immaterial. |
| Reason | Although ongoing training is a statutory obligation, it was not sufficiently prioritized company-wide, and completion by the deadline was prioritized without adequate arrangements for training time, locations, staffing or management systems. |
| Governing Rule | Article 15-11-3, Paragraph 1; Article 147-11-3, Paragraph 1; and Article 149-16, Paragraph 1 of the Enforcement Regulations of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. Articles 36-8 and 36-9 of the Pharmaceuticals and Medical Devices Act. |
| Related previous disclosures | “Notice Regarding the Establishment of the Internal Investigation Committee” dated 22 May 2026 |
| Future plans | The Company will review its operating procedures to separate ongoing training from regular duties, consider introducing online group training and practical training, secure staffing, review workloads, strengthen the management of IDs and passwords, promote company-wide awareness reform, and provide additional training to all registered salespersons. Regarding the voluntary return of directors’ compensation, the Company will promptly disclose the individuals covered, return percentages and period once the Board of Directors has made its decision. |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Ongoing training was not sufficiently prioritized as a company-wide issue, while staffing structures and workload management based on actual conditions at stores, as well as cross-departmental coordination, were inadequate. As a result, completing the training by the deadline was prioritized.